FZD4, FZD5, Wnt5a and RHOU are significantly down-regulated in bone marrow samples from newly diagnosed AML patients compared to normal controls, suggesting a critical role of Wnt signaling pathway in the pathogenesis of AML. The gene discussed is FZD5; the disease is acute myeloid leukemia.